PI3K-like kinases restrain Pim gene expression in endothelial cells

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 32, Issue 1, 2012, Pages 17-23

  Min, Xinwen ^a,b   Tang, Jie ^b   Wang, Yinfang ^b   Yu, Minghua ^b   Zhao, Libing ^b   Yang, Handong ^b   Zhang, Peng ^b   Ma, Yexin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Ataxia telangiectasia mutated; DNA dependent protein kinase catalytic subunit; Endothelial cell; Phosphatidylinositol 3 kinase; Pim 3

Indexed keywords

ATM PROTEIN; ATM PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE PIM 1; PROTO ONCOGENE PROTEINS PIM; PROTO-ONCOGENE PROTEINS PIM;

ARTICLE; CELL CULTURE; CELL FRACTIONATION; DOWN REGULATION; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PHYSIOLOGY;

ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELLS, CULTURED; DOWN-REGULATION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-PIM-1; SUBCELLULAR FRACTIONS;

EID: 84861117814     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-012-0003-0     Document Type: Article

References (31)

1. Mi J, Dziegielewski J, Bolesta E, et al. Activation of DNA-PK by ionizing radiation is mediated by protein phosphatase 6. PLoS One, 2009, 4(2):e4395
2. Kaufmann T, Tai L, Ekert PG, et al. The BH3-only protein bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrest. Cell, 2007, 129(2):423-433
3. Gasser S. DNA damage response and development of targeted cancer treatments. Ann Med, 2007, 39(6):457-464
4. Lee SE, Mitchell RA, Cheng A, et al. Evidence for DNA-PK-dependent and -independent DNA doublestrand break repair pathways in mammalian cells as a function of the cell cycle. Mol Cell Biol, 1997, 17(3): 1425-1433
5. Bailey SM, Brenneman MA, Halbrook J, et al. The kinase activity of DNA-PK is required to protect mammalian telomeres. DNA Repair (Amst), 2004, 3(3):225-233
6. Andreassen PR, D'Andrea AD. Taniguchi T. ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev, 2004, 18(16):1958-1963
7. Luders J, Patel UK, Stearns T. GCP-WD is a gamma-tubulin targeting factor required for centrosomal and chromatin-mediated microtubule nucleation. Nat Cell Biol, 2005, 8(2):137-147
8. Valdman A, Fang X, Pang ST, et al. Pim-1 expression in prostatic intraepithelial neoplasia and human prostate cancer. Prostate, 2004, 60(4):367-371
9. Hu XF, Li J, Vandervalk S, et al. PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis. J Clin Invest, 2009, 119(2):362-375
10. Li YY, Popivanova BK, Naqai Y, et al. Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines. Cancer Res, 2006, 66(13):6741-6747
11. Fox CJ, Hammerman PS, Cinalli RM, et al. The serine/ threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev, 2003, 17(15):1841-1854
12. Ionov Y, Le X, Tunquist BJ, et al. Pim-1 protein kinase is nuclear in Burkitt's lymphoma: nuclear localization is necessary for its biologic effects. Anticancer Res, 2003, 23(1A):167-178
13. Breuer M, Slebos R, Verbeek S, et al. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature, 1989, 340(6228):61-63
14. Zhang P, Wang HQ, Min XW, et al. Pim-3 is expressed in endothelial cells and promotes vascular tube formation. J Cell Physiol, 2009, 220(1):82-90
15. Zippo A, De Robertis A, Bardelli M, et al. Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro. Blood, 2004, 103(12):4536-4544
16. Zhao LB, Wang YF, Min XW, et al. Ischemia-reperfusion injury up-regulates Pim-3 gene expression in myocardial tissue. J Huazhong Univ Sci Technolog Med Sci, 2010, 30(6):704-708
17. Bhattacharya N, Wang Z, Davitt C, et al. Pim-1 associates with protein complexes necessary for mitosis. Chromosoma, 2002, 111(2):80-95
18. Lamalice L, Le Boeuf F, Huot J. Endothelial cell migration during angiogenesis. Circ Res, 2007, 100(6): 782-794
19. Wu X, Shell SM, Yang Z, et al. Phosphorylation of nucleotide excision repair factor xeroderma pigmentosum group A by ataxia telangiectasia mutated and Rad3-related- dependent checkpoint pathway promotes cell survival in response to UV irradiation. Cancer Res, 2006, 66(6):2997-3005
20. Popivanova BK, Li YY, Zheng H, et al. Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis. Cancer Sci, 2007, 98(3):321-328
21. Muraski JA, Rota M, Misao Y, et al. Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat Med, 2007, 13(12):1467-1475
22. Bachmann M, Kosan C, Xing PX, et al. The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C. Int J Biochem Cell Biol, 2006, 38(3):430-443
23. Bachmann M, Hennemann H, Xing PX, et al. The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1): a novel role for Pim-1 at the G2/M cell cycle checkpoint. J Biol Chem, 2004, 279(46):48319-48328
24. Deneen B, Welford SM, Ho T, et al. PIM3 proto-oncogene kinase is a common transcriptional target of divergent EWS/ETS oncoproteins. Mol Cell Biol, 2003, 23(11):3897-3908
25. Krumenacker JS, Buckley DJ, Leff MA, et al. Prolactin- regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expression. Endocrine, 1998, 9(2):163-170
26. Sturgeon CM, Knight ZA, Shokat KM, et al. Effect of combined DNA repair inhibition and G2 checkpoint inhibition on cell cycle progression after DNA damage. Mol Cancer Ther, 2006, 5(4):885-892
27. Moroy T, Grzeschiczek A, Petzold S, et al. Expression of a Pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr/lpr mice. Proc Natl Acad Sci USA, 1993, 90(22):10734-10738
28. Espejel S, Martin M, Klatt P, et al. Shorter telomeres, accelerated ageing and increased lymphoma in DNAPKcs- deficient mice. EMBO Rep, 2004, 5(5):503-509
29. Truman JP, Rotenberg SA, Kang JH, et al. PKCalpha activation downregulates ATM and radio-sensitizes androgen- sensitive human prostate cancer cells in vitro and in vivo. Cancer Biol Ther, 2009, 8(1)54-63
30. Wingett D, Long A, Kelleher D, et al. pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1. J Immunol, 1996, 156(2): 549-557
31. Peltola K, Hollmen M, Maula SM, et al. Pim-1 kinase expression predicts radiation response in squamocellular carcinoma of head and neck and is under the control of epidermal growth factor receptor. Neoplasia, 2009, 11(7): 629-636